These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7377646)

  • 1. [P-450 cytochromes and mono-oxygenases. Mechanism of action. Consequences in pharmacology and toxicology (author's transl)].
    Mansuy D
    Ann Biol Clin (Paris); 1980; 38(1):19-23. PubMed ID: 7377646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of the mono-oxygenase system. Implications in perinatal pharmacotoxicology (author's transl)].
    Cresteil T; Leroux P
    Ann Biol Clin (Paris); 1980; 38(1):57-65. PubMed ID: 6990843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Capacity limited pharmacokinetics, a mechanism of drug toxicity (author's transl)].
    Dettli L
    Arzneimittelforschung; 1977; 27(96):1844-8. PubMed ID: 579151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of cytochrome P450 in the activation of drugs (author's transl)].
    Ullrich V
    Arzneimittelforschung; 1977; 27(96):1821-7. PubMed ID: 579147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological implications of drug metabolism.
    Welch RM
    Pharmacol Rev; 1978 Dec; 30(4):457-67. PubMed ID: 392540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs].
    Ackermann E
    Pharmazie; 1978 Jul; 33(7):400-6. PubMed ID: 364493
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotransformation of drugs in human skin.
    Svensson CK
    Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-drug interactions: how scared should we be?
    Shapiro LE; Shear NH
    CMAJ; 1999 Nov; 161(10):1266-7. PubMed ID: 10584089
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
    Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
    Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds.
    Gillette JR
    Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome p450 and chemical toxicology.
    Guengerich FP
    Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New techniques in drug metabolism and clinical pharmacology/pharmacokinetics.
    Benet LZ
    Am Biotechnol Lab; 1993 Feb; 11(2):44-7. PubMed ID: 7763426
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug-induced hepatits: the role of unstable metabolites (author's transl)].
    Pessayre D; Benhamou JP
    Acta Gastroenterol Belg; 1978; 41(9-10):574-86. PubMed ID: 735686
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity.
    Nelson SD; Trager WF
    Drug Metab Dispos; 2003 Dec; 31(12):1481-98. PubMed ID: 14625345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
    Werner M; Birner G; Dekant W
    Drug Metab Dispos; 1995 Aug; 23(8):861-8. PubMed ID: 7493554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Species differences in drug metabolism - overview from animals to man (author's transl)].
    Kato R
    Jikken Dobutsu; 1981 Oct; 30(4):507-17. PubMed ID: 7318948
    [No Abstract]   [Full Text] [Related]  

  • 17. Considerations of toxicologic interactions in developing new chemicals.
    Wilkinson CF; Murray M
    Drug Metab Rev; 1984; 15(5-6):897-917. PubMed ID: 6396059
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
    Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z
    Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy.
    Chen L; Waxman DJ
    Cancer Res; 1995 Feb; 55(3):581-9. PubMed ID: 7834628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive binding at cytochrome P-450 of cell growth regulatory bioamines, steroid hormones, antihormones, and drugs.
    LaBella FS; Queen GM; Brandes LJ
    J Cell Biochem; 2000 Jan; 76(4):686-94. PubMed ID: 10653987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.